The class of compounds referred to as SMRT/SMRTe inhibitors encompasses a diverse array of chemical entities that have garnered significant interest due to their ability to modulate gene expression through the disruption of interactions involving the Silencing Mediator of Retinoic Acid and Thyroid Hormone Receptor (SMRT) protein. SMRT is a vital corepressor protein that is intricately involved in transcriptional regulation. It forms complexes with various transcription factors, including retinoic acid receptors (RARs) and thyroid hormone receptors (TRs), playing a pivotal role in mediating transcriptional repression by facilitating histone deacetylation and chromatin remodeling at target gene loci. These inhibitors are meticulously designed small molecules that primarily target the interaction interfaces between SMRT and its associated enhancer site, denoted as SMRTe. By selectively disrupting this interaction, these compounds modulate SMRT's repressive influence on gene expression, leading to altered cellular responses. Mechanistically, SMRT/SMRTe inhibitors are thought to bind to specific domains within the SMRT protein that participate in the recruitment of transcriptional corepressor complexes. This impairs the normal formation of the repressive complexes, allowing for enhanced transcriptional activation and gene expression.
Furthermore, some SMRT/SMRTe inhibitors may also exhibit cross-reactivity with other components of the corepressor complexes, such as histone deacetylases (HDACs), thus contributing to their gene regulatory effects. The complex interplay between SMRT, its interacting partners, and the intricate choreography of gene expression regulation underscores the significance of these inhibitors as valuable tools in unraveling the molecular mechanisms governing transcriptional control. Continued research into the design, synthesis, and characterization of SMRT/SMRTe inhibitors holds the promise of shedding light on fundamental biological processes, opening avenues for the development of novel strategies to modulate cellular responses through precise control of gene expression dynamics.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Splitomicin | 5690-03-9 | sc-358701 | 5 mg | $47.00 | ||
Splitomicin is a natural product that has been shown to inhibit both histone deacetylases (HDACs) and SMRT. Its mode of action involves disrupting the interaction between SMRT and HDAC3, leading to altered gene expression. | ||||||
TRAM-34 | 289905-88-0 | sc-201005 sc-201005A | 5 mg 25 mg | $193.00 $607.00 | 10 | |
While primarily known as a blocker of intermediate-conductance calcium-activated potassium channels (IK channels), TRAM-34 has been reported to have off-target effects on SMRT and NCOR1, potentially affecting gene regulation. | ||||||
Chidamide | 743420-02-2 | sc-364462 sc-364462A sc-364462B | 1 mg 5 mg 25 mg | $61.00 $245.00 $1173.00 | ||
Chidamide is a histone deacetylase inhibitor that might also impact SMRT function due to its effects on histone acetylation dynamics. | ||||||
Apicidin | 183506-66-3 | sc-202061 sc-202061A | 1 mg 5 mg | $108.00 $336.00 | 9 | |
Apicidin is a natural compound that can inhibit histone deacetylase activity, which is associated with the SMRT complex. It might indirectly influence SMRT function by altering gene expression. | ||||||